EM1607E "Topics in Anticoagulation" (IM GR-072916)
To discuss important recommendations from the January 2016 Chest Guidelines for Antithrombotic Therapy for VTE Disease and the evidence comparing warfarin with the novel oral anticoagulants in the treatment of venous thromboembolism and atrial fibrillation.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Make reasoned treatment decisions on length of therapy for unprovoked venous thromboembolism
- Be familiar with the major trials comparing warfarin and the novel oral anticoagulants(NOAC)
- State the internet resources for estimating bleeding risk and managing bleeding in a patient on a NOAC
Eric Steen, M.D.
Division of General Internal Medicine
- 1.00 AMA